Oncogenes, Proto-Oncogenes, and Lineage Restriction of Cancer Stem Cells

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2021 Sep 28

PMID 34575830

Citations 11

Authors

Geoffrey Brown

Affiliations

Soon will be listed here.

Abstract

In principle, an oncogene is a cellular gene (proto-oncogene) that is dysfunctional, due to mutation and fusion with another gene or overexpression. Generally, oncogenes are viewed as deregulating cell proliferation or suppressing apoptosis in driving cancer. The cancer stem cell theory states that most, if not all, cancers are a hierarchy of cells that arises from a transformed tissue-specific stem cell. These normal counterparts generate various cell types of a tissue, which adds a new dimension to how oncogenes might lead to the anarchic behavior of cancer cells. It is that stem cells, such as hematopoietic stem cells, replenish mature cell types to meet the demands of an organism. Some oncogenes appear to deregulate this homeostatic process by restricting leukemia stem cells to a single cell lineage. This review examines whether cancer is a legacy of stem cells that lose their inherent versatility, the extent that proto-oncogenes play a role in cell lineage determination, and the role that epigenetic events play in regulating cell fate and tumorigenesis.

Citing Articles

Mechanisms of Antitumor Activity of Low Doses of Radiation Associated with Activation of Cells' Defense System.

Fomina D, Rozhdestvensky L, Raeva N, Vorobeva E, Zasukhina G Dokl Biochem Biophys. 2025; .

PMID: 39847289 DOI: 10.1134/S160767292470128X.

FAT1 knockdown enhances the CSC properties of HNSCC through p-CaMKII-mediated inactivation of the IFN pathway.

Wang J, Chen Y, Sun Y, Liu H, Du R, Wang X Int J Biol Sci. 2025; 21(2):671-684.

PMID: 39781458 PMC: 11705627. DOI: 10.7150/ijbs.95723.

Status Quo in the Liposome-Based Therapeutic Strategies Against Glioblastoma: "Targeting the Tumor and Tumor Microenvironment".

Haseeb M, Khan I, Kartal Z, Mahfooz S, Hatiboglu M Int J Mol Sci. 2024; 25(20).

PMID: 39457052 PMC: 11509082. DOI: 10.3390/ijms252011271.

Characterization of tumor suppressors and oncogenes evaluated from TCGA cancers.

Shen C, Geng R, Zhu S, Huang M, Liang J, Li B Am J Clin Exp Immunol. 2024; 13(4):187-194.

PMID: 39310123 PMC: 11411158. DOI: 10.62347/XMZW6604.

Harnessing Artificial Intelligence for the Detection and Management of Colorectal Cancer Treatment.

Jacob M, Reddy R, Garcia R, Reddy A, Khemka S, Roghani A Cancer Prev Res (Phila). 2024; 17(11):499-515.

PMID: 39077801 PMC: 11534518. DOI: 10.1158/1940-6207.CAPR-24-0178.

References

Kinoshita M, Li M, Barber M, Mansfield W, Dietmann S, Smith A . Disabling de novo DNA methylation in embryonic stem cells allows an illegitimate fate trajectory. Proc Natl Acad Sci U S A. 2021; 118(38). PMC: 8463881. DOI: 10.1073/pnas.2109475118. View

Raboso-Gallego J, Casado-Garcia A, Jiang X, Isidro-Hernandez M, Gentles A, Zhao S . Conditional expression of HGAL leads to the development of diffuse large B-cell lymphoma in mice. Blood. 2020; 137(13):1741-1753. PMC: 8020264. DOI: 10.1182/blood.2020004996. View

Liu Y, Cheng Z, Pang Y, Cui L, Qian T, Quan L . Role of microRNAs, circRNAs and long noncoding RNAs in acute myeloid leukemia. J Hematol Oncol. 2019; 12(1):51. PMC: 6534901. DOI: 10.1186/s13045-019-0734-5. View

Troppan K, Wenzl K, Neumeister P, Deutsch A . Molecular Pathogenesis of MALT Lymphoma. Gastroenterol Res Pract. 2015; 2015:102656. PMC: 4397421. DOI: 10.1155/2015/102656. View

Lacaud G, Gore L, Kennedy M, Kouskoff V, Kingsley P, Hogan C . Runx1 is essential for hematopoietic commitment at the hemangioblast stage of development in vitro. Blood. 2002; 100(2):458-66. DOI: 10.1182/blood-2001-12-0321. View

Agraz-Doblas A, Bueno C, Bashford-Rogers R, Roy A, Schneider P, Bardini M . Unraveling the cellular origin and clinical prognostic markers of infant B-cell acute lymphoblastic leukemia using genome-wide analysis. Haematologica. 2019; 104(6):1176-1188. PMC: 6545849. DOI: 10.3324/haematol.2018.206375. View

Athanasiou M, Mavrothalassitis G, Blair D . FLI-1 is a suppressor of erythroid differentiation in human hematopoietic cells. Leukemia. 2000; 14(3):439-45. DOI: 10.1038/sj.leu.2401689. View

Jabara H, Ohsumi T, Chou J, Massaad M, Benson H, Megarbane A . A homozygous mucosa-associated lymphoid tissue 1 (MALT1) mutation in a family with combined immunodeficiency. J Allergy Clin Immunol. 2013; 132(1):151-8. PMC: 3700575. DOI: 10.1016/j.jaci.2013.04.047. View

Greaves M . Molecular genetics, natural history and the demise of childhood leukaemia. Eur J Cancer. 1999; 35(2):173-85. DOI: 10.1016/s0959-8049(98)00433-x. View

10.

Creyghton M, Cheng A, Welstead G, Kooistra T, Carey B, Steine E . Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc Natl Acad Sci U S A. 2010; 107(50):21931-6. PMC: 3003124. DOI: 10.1073/pnas.1016071107. View

11.

Kang H, Shokhirev M, Xu Z, Chandran S, Dixon J, Hetzer M . Dynamic regulation of histone modifications and long-range chromosomal interactions during postmitotic transcriptional reactivation. Genes Dev. 2020; 34(13-14):913-930. PMC: 7328517. DOI: 10.1101/gad.335794.119. View

12.

Ladanyi M . Fusions of the SYT and SSX genes in synovial sarcoma. Oncogene. 2001; 20(40):5755-62. DOI: 10.1038/sj.onc.1204601. View

13.

Kim M, Costello J . DNA methylation: an epigenetic mark of cellular memory. Exp Mol Med. 2017; 49(4):e322. PMC: 6130213. DOI: 10.1038/emm.2017.10. View

14.

Greaves M . A causal mechanism for childhood acute lymphoblastic leukaemia. Nat Rev Cancer. 2018; 18(8):471-484. PMC: 6986894. DOI: 10.1038/s41568-018-0015-6. View

15.

Barco R, Garcia C, Eid J . The synovial sarcoma-associated SYT-SSX2 oncogene antagonizes the polycomb complex protein Bmi1. PLoS One. 2009; 4(4):e5060. PMC: 2659801. DOI: 10.1371/journal.pone.0005060. View

16.

Remstein E, Kurtin P, Einerson R, Paternoster S, Dewald G . Primary pulmonary MALT lymphomas show frequent and heterogeneous cytogenetic abnormalities, including aneuploidy and translocations involving API2 and MALT1 and IGH and MALT1. Leukemia. 2003; 18(1):156-60. DOI: 10.1038/sj.leu.2403185. View

17.

Takahashi K, Yamanaka S . Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006; 126(4):663-76. DOI: 10.1016/j.cell.2006.07.024. View

18.

Garcia-Ramirez I, Bhatia S, Rodriguez-Hernandez G, Gonzalez-Herrero I, Walter C, de Tena-Davila S . Lmo2 expression defines tumor cell identity during T-cell leukemogenesis. EMBO J. 2018; 37(14). PMC: 6043907. DOI: 10.15252/embj.201798783. View

19.

Lu X, Sicard R, Jiang X, Stockus J, McNamara G, Abdulreda M . HGAL localization to cell membrane regulates B-cell receptor signaling. Blood. 2014; 125(4):649-57. PMC: 4304110. DOI: 10.1182/blood-2014-04-571331. View

20.

Jiang X, Huang H, Li Z, He C, Li Y, Chen P . MiR-495 is a tumor-suppressor microRNA down-regulated in MLL-rearranged leukemia. Proc Natl Acad Sci U S A. 2012; 109(47):19397-402. PMC: 3511140. DOI: 10.1073/pnas.1217519109. View